Vespa Capital has backed Eserv to accelerate international expansion and technology development.
"After performing a strategic review we set out to find an investment partner that would help strengthen our balance sheet to super charge our international growth plan, as well as further invest into our staff and technology development. Vespa Capital was able to demonstrate a very credible track record of growing technology enabled companies and adding real value to management teams through mentoring."
The pre-seed round was led by Jenson Funding Partners to help expand clinical trial software across UK and Irish hospitals.
"We are delighted in raising investment from Jenson Funding Partners and continuing our incredible journey with their support. AscensionQ was created to tackle the everyday challenges researchers face through automation in one platform, connecting people and not just processes. It has been fantastic working with the research community to create ‘a first of its kind’ research clinic operating system. From well-established research institutions through to newer organisations, the AQ platform has shown to increase clinical trial capacity for hospitals, improve patient recruitment and retention and support the business opportunity that research presents for NHS trusts. Our ‘buy-once, use many’ philosophy has enabled our customers to do more with less. 2022 was great validation of our system and for 2023 we are excited to push on and help the thousands of research clinics in the UK and beyond."
Clean Growth Fund led the financing round alongside backers including Vectr7 Investment Partners and MMC Ventures to support research and recruitment.
"Our technology offers a simple solution for office occupiers who are under pressure to take action and cut energy costs and reduce emissions. Our solution can pay back financially within two years and allows business customers to reduce their electricity bills by at least 20%."
